Study of MWN109 tablets in healthy adults
Part of Hormones & metabolism clinical trials.
This trial tests a new tablet called MWN109 in healthy adults to see how safe it is and how the body handles it. It has two parts: one for people with a wide range of body weights, and another specifically for people with higher body weight. The results will help guide future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- Your weight is between 65 kg (143 lbs) and 130 kg (286 lbs). Depending on the part of the study, if your body mass index (BMI) is between 19 and 40, or between 27 and 45.
- Your weight has been stable (not changed more than 5%) in the last 3 months.
- You are generally healthy, with no major heart, liver, kidney, stomach, or other medical issues.
- You agree to use contraception (if applicable) or are past childbearing years, and will not donate sperm or eggs during the study and for 4 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational injection called MWN109 to see if it is safe and how the body processes it. It is for healthy adults only, and the results will help decide if the drug should be tested in people with medical conditions.
This study tests a new investigational injection called MWN110 in people who are overweight or have obesity. The goal is to see if the drug is safe and how it affects the body, which may help with weight management.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This study tests an experimental pill (GZC8072) for weight loss. It is a phase 1 trial, meaning it is one of the first times the drug is given to people, and the focus is on safety and how the body handles it. You would receive either a single dose (if you are healthy) or multiple doses (if you are overweight or obese) to see how the medication works.
This trial tests an investigational injection called MWN109 to help adults with overweight or obesity lose weight. It is a phase 3 study, meaning it is being tested in a large group of people to see how well it works and if it is safe.
This early-stage study tests a new investigational drug (called WD-910) in healthy volunteers to see how safe it is, how the body processes it, and how it affects the body. You would receive either the drug or a placebo (a pill with no active medicine), and doctors will monitor you closely.
Hear when a new Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.